Myocyte enhancer factor 2C (MEF2C)

Myocyte enhancer factor 2C (MEF2C) is a member of the MEF2 transcription factor family within the MADS-box superfamily. MEF2C plays a critical role in the early development, differentiation, and maintenance of multiple cell types, including skeletal, cardiac, and smooth muscle, as well as neural, chondroid, immune, and endothelial cells. It regulates the expression of genes required for cell fate, morphogenesis, and tissue integrity. Loss or dysregulation of MEF2C leads to severe developmental defects, particularly in the cardiovascular and musculoskeletal systems, and is implicated in neurodevelopmental and oncological disorders. MEF2C functions by binding specific DNA motifs as a dimer and interacting with a variety of co-factors, influencing a wide array of downstream gene networks.

Other names

MEF2CMyocyte-specific enhancer factor 2CMADS box transcription enhancer factor 2, polypeptide C

Drugs or experimental compounds targeting MEF2C typically act as transcriptional modulators, either inhibiting or enhancing MEF2C-mediated gene transcription, affecting downstream gene networks involved in differentiation, survival, or proliferation. Indirect mechanisms may include modulation via its regulators or cofactors.